Cargando…

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance

Streptococcus pneumoniae related diseases are a leading cause of morbidity and mortality, especially in children and in the elderly population. It is transmitted to other individuals through droplets and it can spread to other parts of the human host, causing a wide spectrum of clinical syndromes, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scelfo, Chiara, Menzella, Francesco, Fontana, Matteo, Ghidoni, Giulia, Galeone, Carla, Facciolongo, Nicola Cosimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145843/ https://www.ncbi.nlm.nih.gov/pubmed/33922273 http://dx.doi.org/10.3390/vaccines9050420

Ejemplares similares

Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021)

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020)

Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021)

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports
por: Scelfo, Chiara, et al.
Publicado: (2020)

A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
por: Menzella, Francesco, et al.
Publicado: (2021)

Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling
por: Facciolongo, Nicola, et al.
Publicado: (2022)

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?
por: Galeone, Carla, et al.
Publicado: (2018)

Towards precision medicine: The application of omics technologies in asthma management
por: Scelfo, Chiara, et al.
Publicado: (2018)

COVID-19: general overview, pharmacological options and ventilatory support strategies
por: Menzella, Francesco, et al.
Publicado: (2020)

Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life
por: Menzella, Francesco, et al.
Publicado: (2022)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
por: Fernández-Delgado, Lucía, et al.
Publicado: (2021)

Piliation of Invasive Streptococcus pneumoniae Isolates in the Era before Pneumococcal Conjugate Vaccine Introduction in Malawi
por: Kulohoma, Benard W., et al.
Publicado: (2013)

Incidence of Invasive Pneumococcal Disease Before and During an Era of Use of Three Different Pneumococcal Conjugate Vaccines in Quebec
por: De Wals, Philippe, et al.
Publicado: (2017)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab
por: Menzella, Francesco, et al.
Publicado: (2019)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?
por: Menzella, Francesco, et al.
Publicado: (2017)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

May 2020: Is It Always COVID-19 No Matter What?
por: Livrieri, Francesco, et al.
Publicado: (2020)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021)

2717. The Impact of Pneumococcal Conjugate Vaccine in Nonbacteremic Pneumococcal Pneumonia Among Cancer Patients
por: Lee, Yeon Joo, et al.
Publicado: (2019)

Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance
por: Mackenzie, Grant A, et al.
Publicado: (2021)

Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era
por: Marom, Tal, et al.
Publicado: (2020)

Recent Trends in Invasive Pneumococcal Disease in Korea in the Post-pneumococcal Vaccine Era
por: Huh, Hee Jae, et al.
Publicado: (2023)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017)

Efficacy and safety of EBUS‐TBNA under conscious sedation with meperidine and midazolam
por: Piro, Roberto, et al.
Publicado: (2022)

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
por: Rückinger, Simon, et al.
Publicado: (2010)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2013)

1430. Evolving Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease
por: Yildirim, Inci, et al.
Publicado: (2018)

State of the Globe: Effect of Pneumococcal Conjugate Vaccines on Nonvaccine-type Invasive Pneumococcal Disease
por: Raina, Sunil Kumar
Publicado: (2019)

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study
por: Chan, Jocelyn, et al.
Publicado: (2021)

2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults
por: Lewis, Ned, et al.
Publicado: (2019)

Comparison of the clinical features of invasive pneumococcal disease with those of pneumococcal pneumonia in adults
por: Kuroki, Akane, et al.
Publicado: (2022)

1003. Clinical Implications of Emerging Nonvaccine-Serotype Invasive Pneumococcal Disease Among Adults in the Republic of Korea in the Era of Protein-Conjugated Pneumococcal Vaccine
por: Kim, Jong Hun, et al.
Publicado: (2018)

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use
por: Baxter, Roger, et al.
Publicado: (2020)

647 Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States
por: Kim, Lindsay, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_15vqlevtkfaoocuf5kva5sfgem